Medical Research
(H96Z)
IRS Verified
DX Registered
NEUROFIBROMATOSIS MIDWEST
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$241K
Total Revenue
$263K
Total Expenses
$293K
Net Assets
6
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
78.1%
Fundraising Efficiency
0.0%
Operating Reserve
13.38x
Liability-to-Asset
0.3%
Revenue Diversification
95.5%
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $241K | $263K | $293K | 78.1% | 6 |
| 2022 | $221K | $218K | N/A | — | 6 |
| 2021 | $210K | $176K | N/A | — | 5 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.